| Product NDC: | 43353-724 | 
| Proprietary Name: | LANOXIN | 
| Non Proprietary Name: | digoxin | 
| Active Ingredient(s): | 250 ug/1 & nbsp; digoxin | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 43353-724 | 
| Labeler Name: | Aphena Pharma Solutions - Tennessee, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020405 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19840702 | 
| Package NDC: | 43353-724-30 | 
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (43353-724-30) | 
| NDC Code | 43353-724-30 | 
| Proprietary Name | LANOXIN | 
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (43353-724-30) | 
| Product NDC | 43353-724 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | digoxin | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 19840702 | 
| Marketing Category Name | NDA | 
| Labeler Name | Aphena Pharma Solutions - Tennessee, Inc. | 
| Substance Name | DIGOXIN | 
| Strength Number | 250 | 
| Strength Unit | ug/1 | 
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |